EyePoint Pharmaceuticals Inc. buy Capital One Financial Co.
Start price
11.12.23
/
50%
€18.40
Target price
11.12.24
€40.94
Performance (%)
-56.86%
End price
12.12.24
€7.94
Summary
This prediction ended on 12.12.24 with a price of €7.94. Massive losses of -56.86% were the result for the BUY prediction by Capital_One_Financia. Capital_One_Financia has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -2.727% | -2.727% | 23.357% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Capital_One_Financia for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $44.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten